Dark Forest Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Dark Forest Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$585K	Sell	40,451 -99,849	-71%	-$1.43M	0.05%	522
2025 Q4	$2M	Buy	+140,300	New	+$1.38M	0.09%	386
2025 Q3	–	Sell	-311,561	Closed	-$1.79M	–	1262
2025 Q2	$1.79M	Sell	311,561 -315,276	-50%	-$2.03M	0.07%	496
2025 Q1	$5.11M	Buy	626,837 +588,689	+1,543%	+$5.45M	0.23%	71
2024 Q4	$359K	Buy	+38,148	New	+$397K	0.05%	581
2022 Q1	–	Sell	-667	Closed	-$8K	–	1441
2021 Q4	$8K	Sell	667 -4,171	-86%	-$46.5K	﹤0.01%	1004
2021 Q3	$46K	Buy	4,838 +4,604	+1,968%	+$47.1K	0.02%	590
2021 Q2	$2K	Buy	+234	New	+$2.28K	﹤0.01%	754

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Dark Forest Capital Management's FOLD Position: Q1 2026 in Review

Dark Forest Capital Management reduced its Amicus Therapeutics (FOLD) stake by 71% in Q1 2026, selling an estimated $1.43M and leaving 40,451 shares worth $585K. The position accounts for 0.05% of the portfolio, ranked #522.

Dark Forest Capital Management first reported a position in FOLD in Q2 2021 and has held it in 8 quarters since. The position peaked at $5.11M in Q1 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Dark Forest Capital Management held 40,451 shares of Amicus Therapeutics worth $585K as of Q1 2026.
Dark Forest Capital Management sold 99,849 Amicus Therapeutics shares in Q1 2026, an estimated $1.43M.
Amicus Therapeutics made up 0.05% of Dark Forest Capital Management's portfolio in Q1 2026, its #522 holding.
Dark Forest Capital Management first reported a position in Amicus Therapeutics in Q2 2021 and has held it in 8 quarters since.
Dark Forest Capital Management's Amicus Therapeutics position peaked at $5.11M in Q1 2025.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.